Psoriasis patient’s mental health is more than skin-deep

 

Umeå, Sweden (June 4, 2020) — Treatment of the common disease psoriasis, usually focuses on treating the skin. However, psoriasis patients often have other physical diseases that can bring on depression, anxiety, and suicide. A new study from Umeå University, Sweden, shows that these other somatic diseases have even more impact on patients‘ mental health than their skin symptoms, highlighting the importance of holistic patient care.

Psoriasis is a lifelong disease. The body produces skin cells too quickly which build up on the skin’s surface in the form of inflamed red, painful, itchy scales. Many people with psoriasis have other physical diseases such as being overweight, diabetes and heart diseases.

„What we didn’t know before is how psoriasis skin symptoms and other somatic diseases associated with psoriasis impact mental health,“ says Marcus Schmitt-Egenolf, Dermatologist and Professor at Umeå University.

Previous research found that people with psoriasis suffer more often from somatic and mental diseases compared to individuals without psoriasis. A new study confirmed this. The study also investigated how psoriasis skin symptoms and associated somatic diseases impacted mental health, considering anxiety, depression and suicide together.

The study found that skin symptoms have an important impact on mental health, but that other somatic diseases associated with psoriasis can cause even more harm to mental health.

„We found that skin symptoms increased the risk of mental illness by a third, while other physical illnesses doubled the risk among psoriasis patients,“ says Kirk Geale, PhD candidate at Umeå University. The results in the study shows a 32 percent increase risk of mental illness caused by skin symptoms and a 109 percent increased risk at other somatic illnesses.

This information is important as the total burden of mental health burden for people with psoriasis, and what contributes to it, was not well established. The study’s findings encourage people with psoriasis to talk with their doctors more about symptoms beyond the skin, both physical and mental. It also encourages doctors to proactively discuss these issues with their patients.

„I would be delighted if our study could support the trend towards a more holistic view on psoriasis care. At the doctor’s office, lifestyle factors should be discussed in the awareness that individual responsiblity may be limited by available personal and community resources. Such an approach may improve the complete triad of psoriasis – skin symptoms, somatic and mental health alike,“ concludes Marcus Schmitt-Egenolf.

The study was conducted during 2017 – 2019. Nationwide data from about 100.000 individuals with psoriasis but without earlier mental diseases in Sweden were compared to a control group without psoriasis. The study is published in JAMA Dermatology.

 


Umea University, 20.04.2020 (tB).

Schlagwörter: , ,

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…